Supplemental Financial Statement Information (Tables)

12 Months Ended

Dec. 31, 2019

Additional Financial Information Disclosure [Abstract]

Schedule of cash and cash equivalents

Cash and cash equivalents at December 31, 2019 and 2018 were as follows:

(In millions)	2019		2018
Cash	$	190.8	$	264.4
Other short-term investments	300.0		117.6
Total cash and cash equivalents	$	490.8	$	382.0

Schedule of other non-operating income (expense)

Other income (expense) for the years ended December 31, 2019, 2018, and 2017 was as follows:

(in millions)	2019			2018			2017
Rent, royalty income and other income	$	2.9		$	3.1		$	3.5
Gains from disposal of property, plant and equipment, net	90.7			1.3			0.5
Equity loss on joint ventures (See Note 7)	(10.7		)	(1.0		)	—
Loss on sales of businesses, net (See Note 6)	(1.9		)	—			—
Gain on joint venture deconsolidation (See Note 7)	—			15.9			—
Joint venture impairment charge (See Note 7)	(11.4		)	—			—
Other	0.1			1.2			—
Total other income, net	$	69.7		$	20.5		$	4.0